应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
PODD 银休特
休市中 05-01 16:00:00 EDT
175.04
+2.90
+1.68%
盘后
171.61
-3.43
-1.96%
18:55 EDT
最高
178.04
最低
172.08
成交量
128.19万
今开
174.19
昨收
172.14
日振幅
3.46%
总市值
121.24亿
流通市值
121.24亿
总股本
6,926万
成交额
2.25亿
换手率
1.85%
流通股本
6,926万
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
数据加载中...
北京优虎网络科技有限公司
资讯
新帖
简况
FDA最新数据:截至4月17日,银休特公司报告476例严重伤害事件与特定Omnipod 5胰岛素泵问题相关
美股速递 · 04-29
FDA最新数据:截至4月17日,银休特公司报告476例严重伤害事件与特定Omnipod 5胰岛素泵问题相关
FDA公告:银休特于4月10日向受影响客户发出更新信函 扩大Omnipod 5胰岛素泵受影响批次清单
美股速递 · 04-29
FDA公告:银休特于4月10日向受影响客户发出更新信函 扩大Omnipod 5胰岛素泵受影响批次清单
财报前瞻|银休特本季营收预计增34.04%,机构观点偏多
财报Agent · 04-29
财报前瞻|银休特本季营收预计增34.04%,机构观点偏多
银休特公布针对2型糖尿病成人患者的全闭环自动胰岛素输送系统积极研究结果
美股速递 · 03-12
银休特公布针对2型糖尿病成人患者的全闭环自动胰岛素输送系统积极研究结果
银休特公司首席执行官阿什利·麦基沃伊于2月20日以均价239.35美元/股公开市场购入4300股公司普通股 - 美国证交会文件披露
美股速递 · 02-23
银休特公司首席执行官阿什利·麦基沃伊于2月20日以均价239.35美元/股公开市场购入4300股公司普通股 - 美国证交会文件披露
异动解读 | 业绩超预期且宣布股票回购,银休特盘中大涨9.57%
异动解读 · 02-18
异动解读 | 业绩超预期且宣布股票回购,银休特盘中大涨9.57%
异动解读 | 业绩超预期且宣布股票回购,银休特盘前大涨5.14%
异动解读 · 02-18
异动解读 | 业绩超预期且宣布股票回购,银休特盘前大涨5.14%
银休特公司计划于2026年第一季度斥资约3亿美元进行股票回购
美股速递 · 02-18
银休特公司计划于2026年第一季度斥资约3亿美元进行股票回购
银休特宣布Omnipod® 5算法增强通过FDA 510(K)清关,重新定义胰岛素输送并简化Pod体验
美股速递 · 2025-12-04
银休特宣布Omnipod® 5算法增强通过FDA 510(K)清关,重新定义胰岛素输送并简化Pod体验
银休特盘中异动 股价大涨5.02%
市场透视 · 2025-11-22
银休特盘中异动 股价大涨5.02%
异动解读 | 银休特季度业绩超预期,股价却盘中大跌5.11%
异动解读 · 2025-11-07
异动解读 | 银休特季度业绩超预期,股价却盘中大跌5.11%
异动解读 | 银休特盘中大涨5.25%,季度业绩超预期且上调全年指引
异动解读 · 2025-11-06
异动解读 | 银休特盘中大涨5.25%,季度业绩超预期且上调全年指引
银休特盘中异动 早盘大幅跳水5.00%报239.22美元
市场透视 · 2025-03-10
银休特盘中异动 早盘大幅跳水5.00%报239.22美元
银休特盘中异动 大幅跳水5.17%报268.83美元
市场透视 · 2025-02-25
银休特盘中异动 大幅跳水5.17%报268.83美元
银休特2024财年实现净利润4.18亿美元,同比增加102.91%
市场透视 · 2025-02-24
银休特2024财年实现净利润4.18亿美元,同比增加102.91%
花旗:维持Insulet(PODD.US)评级,由买入调整至买入评级, 目标价由310.00美元调整至355.00美元。
金融界 · 2025-02-22
花旗:维持Insulet(PODD.US)评级,由买入调整至买入评级, 目标价由310.00美元调整至355.00美元。
雷蒙德詹姆斯公司:重申Insulet(PODD.US)评级,由优于大市调整至优于大市评级, 目标价由294.00美元调整至328.00美元。
金融界 · 2025-02-22
雷蒙德詹姆斯公司:重申Insulet(PODD.US)评级,由优于大市调整至优于大市评级, 目标价由294.00美元调整至328.00美元。
Stifel:维持Insulet(PODD.US)评级,由持有调整至持有评级, 目标价由245.00美元调整至293.00美元。
金融界 · 2025-02-21
Stifel:维持Insulet(PODD.US)评级,由持有调整至持有评级, 目标价由245.00美元调整至293.00美元。
加拿大投资银行集团:维持Insulet(PODD.US)评级,由买入调整至买入评级, 目标价由304.00美元调整至324.00美元。
金融界 · 2025-02-21
加拿大投资银行集团:维持Insulet(PODD.US)评级,由买入调整至买入评级, 目标价由304.00美元调整至324.00美元。
Insulet 2024年第四季度调整后每股收益 $1.15 超预期 $1.02,营收 $597.50M 超预期 $582.81M
财报速递 · 2025-02-21
Insulet 2024年第四季度调整后每股收益 $1.15 超预期 $1.02,营收 $597.50M 超预期 $582.81M
加载更多
公司概况
公司名称:
银休特
所属市场:
NASDAQ
上市日期:
--
主营业务:
Insulet Corporation是于2000年成立的一家特拉华州的公司。该公司主要从事开发、制造和销售其专有的胰岛素持续递送系统,用于胰岛素依赖型糖尿病患者。Omnipod平台包括:Omnipod 5自动胰岛素输送系统、Omnipod DASH胰岛素管理系统、Omnipod胰岛素管理系统和最新创新产品Omnipod GOTM,于2023年获得美国食品和药物管理局的许可。该公司还为安进生产Pods,用于Neulasta Onpro试剂盒,这是一种用于安进的Neulasta的递送系统,可帮助降低密集化疗后的感染风险。
发行价格:
--
{"stockData":{"symbol":"PODD","market":"US","secType":"STK","nameCN":"银休特","latestPrice":175.04,"timestamp":1777665600000,"preClose":172.14,"halted":0,"volume":1281933,"hourTrading":{"tag":"盘后","latestPrice":171.61,"preClose":175.04,"latestTime":"18:55 EDT","volume":18928,"amount":3312155.64,"timestamp":1777676144970,"change":-3.43,"changeRate":-0.019596,"amplitude":0.019596},"delay":0,"changeRate":0.016846752643197432,"floatShares":69263700,"shares":69263700,"eps":3.479119,"marketStatus":"休市中","change":2.9,"latestTime":"05-01 16:00:00 EDT","open":174.19,"high":178.04,"low":172.08,"amount":225179864.0145,"amplitude":0.034623,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":3.479119,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1777881600000},"marketStatusCode":7,"adr":0,"adrRate":0,"listingDate":1179201600000,"exchange":"NASDAQ","adjPreClose":172.14,"preHourTrading":{"tag":"盘前","latestPrice":172.5,"preClose":172.14,"latestTime":"09:25 EDT","volume":184,"amount":31781.449679999998,"timestamp":1777641929975,"change":0.36,"changeRate":0.002091,"amplitude":0.056057},"postHourTrading":{"tag":"盘后","latestPrice":171.61,"preClose":175.04,"latestTime":"18:55 EDT","volume":18928,"amount":3312155.64,"timestamp":1777676144970,"change":-3.43,"changeRate":-0.019596,"amplitude":0.019596},"volumeRatio":0.6734339912410885,"impliedVol":0.6235,"impliedVolPercentile":0.9841},"requestUrl":"/m/hq/s/PODD","defaultTab":"news","newsList":[{"id":"1168888894","title":"FDA最新数据:截至4月17日,银休特公司报告476例严重伤害事件与特定Omnipod 5胰岛素泵问题相关","url":"https://stock-news.laohu8.com/highlight/detail?id=1168888894","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1168888894?lang=zh_cn&edition=full","pubTime":"2026-04-29 23:50","pubTimestamp":1777477843,"startTime":"0","endTime":"0","summary":"美国食品药品监督管理局披露最新监管数据显示,胰岛素泵制造商银休特公司已确认其特定型号Omnipod 5产品存在潜在风险。截至4月17日统计时段,企业累计上报476起严重伤害病例报告,所幸暂未出现致死案例。监管部门强调将持续监测该医疗器械的安全性表现,并要求企业完善风险管控措施。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4566","LU2065170008.USD","LU2324357040.USD","BK4588","LU0728928796.USD","BK4585","BK4551","LU2065169927.USD","PODD","LU2065171402.SGD","LU2065171311.SGD","BK4082","LU1119994496.HKD","LU1084165304.USD","LU1261432733.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1195710328","title":"FDA公告:银休特于4月10日向受影响客户发出更新信函 扩大Omnipod 5胰岛素泵受影响批次清单","url":"https://stock-news.laohu8.com/highlight/detail?id=1195710328","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1195710328?lang=zh_cn&edition=full","pubTime":"2026-04-29 23:49","pubTimestamp":1777477795,"startTime":"0","endTime":"0","summary":"美国食品药品监督管理局披露最新动态——医疗设备制造商银休特已于4月10日向所有受影响客户寄发更新通知函,进一步扩展了Omnipod 5胰岛素泵 pods 的受影响产品批次范围。此次行动标志着该企业正在持续完善产品安全监测体系,通过主动扩大通报范围强化用户风险管控。\n作为糖尿病管理领域的创新解决方案,Omnipod 5胰岛素泵系统的质量控制始终备受关注。银休特此次及时更新受影响批次清单的举措,既体现了企业对监管要求的积极响应,也展现出对用户健康安全的高度负责态度。医疗器械的安全使用关乎患者生命健康,此类透明度提升行动将有助于医疗专业人员与患者共同构建更完善的风险防范机制。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1261432733.SGD","LU0728928796.USD","LU2324357040.USD","BK4551","BK4082","BK4566","LU2065169927.USD","LU2065171311.SGD","PODD","LU2065171402.SGD","LU1119994496.HKD","LU2065170008.USD","LU1084165304.USD","BK4588","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1194759384","title":"财报前瞻|银休特本季营收预计增34.04%,机构观点偏多","url":"https://stock-news.laohu8.com/highlight/detail?id=1194759384","media":"财报Agent","labels":["earningPreview"],"top":1,"itemType":null,"share":"https://www.laohu8.com/m/news/1194759384?lang=zh_cn&edition=full","pubTime":"2026-04-29 11:03","pubTimestamp":1777431791,"startTime":"0","endTime":"0","summary":"银休特将于2026年05月06日发布最新季度财报,市场围绕营收增速与盈利修复展开博弈,关注指引与回购执行节奏。市场一致预期本季度银休特营收为7.28亿美元,同比增长34.04%;调整后每股收益为1.20美元,同比增长50.65%。上季度银休特营收为7.84亿美元,同比增长31.18%;毛利率为72.54%;归属于母公司股东的净利润为1.02亿美元,净利率为12.96%;调整后每股收益为1.55美元,同比增长34.78%。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"财报前瞻|银休特本季营收预计增34.04%,机构观点偏多","news_tag":"earningPreview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PODD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1106867655","title":"银休特公布针对2型糖尿病成人患者的全闭环自动胰岛素输送系统积极研究结果","url":"https://stock-news.laohu8.com/highlight/detail?id=1106867655","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1106867655?lang=zh_cn&edition=full","pubTime":"2026-03-12 04:03","pubTimestamp":1773259395,"startTime":"0","endTime":"0","summary":"银休特公司近日公布了其针对2型糖尿病成人患者研发的全闭环自动胰岛素输送系统的研究数据,结果显示该系统表现出了令人鼓舞的应用前景。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4082","LU2324357040.USD","BK4566","BK4551","LU1119994496.HKD","LU2065169927.USD","LU2065170008.USD","LU2065171402.SGD","BK4588","LU1084165304.USD","LU0728928796.USD","LU2065171311.SGD","LU1261432733.SGD","PODD","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1150849480","title":"银休特公司首席执行官阿什利·麦基沃伊于2月20日以均价239.35美元/股公开市场购入4300股公司普通股 - 美国证交会文件披露","url":"https://stock-news.laohu8.com/highlight/detail?id=1150849480","media":"美股速递","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1150849480?lang=zh_cn&edition=full","pubTime":"2026-02-23 21:22","pubTimestamp":1771852937,"startTime":"0","endTime":"0","summary":"根据一份提交给美国证券交易委员会(SEC)的文件显示,医疗设备公司银休特的首席执行官阿什利·麦基沃伊于2月20日在公开市场进行了一次股票交易。此次交易中,麦基沃伊购入了4300股银休特公司的普通股。文件进一步披露,这笔交易的成交均价为每股239.35美元。公司高管的此类公开市场买入行为,通常被市场参与者视为其对公司的未来发展抱有信心的信号。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4082","LU2324357040.USD","BK4566","BK4551","LU1119994496.HKD","LU2065169927.USD","LU2065170008.USD","LU2065171402.SGD","BK4588","LU1084165304.USD","LU0728928796.USD","LU2065171311.SGD","LU1261432733.SGD","PODD","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1199559459","title":"异动解读 | 业绩超预期且宣布股票回购,银休特盘中大涨9.57%","url":"https://stock-news.laohu8.com/highlight/detail?id=1199559459","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1199559459?lang=zh_cn&edition=full","pubTime":"2026-02-18 22:39","pubTimestamp":1771425566,"startTime":"0","endTime":"0","summary":"医疗设备制造商银休特(PODD)今日盘中股价大幅上涨9.57%,引起了市场的广泛关注。消息面上,公司公布的第四季度业绩表现强劲,营收和调整后每股收益均超出市场预期,主要得益于其无管胰岛素泵Omnipod需求的持续旺盛。同时,公司对2026年全年及第一季度业绩给出了乐观指引,预计收入将实现显著增长,这为投资者注入了强大信心。此外,公司宣布增加股票回购授权,并计划在近期动用约3亿美元进行回购。这一资本配置举措彰显了管理层对公司未来现金流和增长前景的信心,旨在优化资本结构并回馈股东,进一步推动了股价的积极表现。","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["PODD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1102415991","title":"异动解读 | 业绩超预期且宣布股票回购,银休特盘前大涨5.14%","url":"https://stock-news.laohu8.com/highlight/detail?id=1102415991","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1102415991?lang=zh_cn&edition=full","pubTime":"2026-02-18 21:05","pubTimestamp":1771419930,"startTime":"0","endTime":"0","summary":"医疗设备制造商银休特(PODD)今日盘前股价大幅上涨5.14%,引发市场关注。消息面上,公司公布的第四季度业绩表现强劲,营收和调整后每股收益均超出市场预期,主要得益于其无管胰岛素泵Omnipod需求的持续旺盛。同时,公司对2026年全年业绩给出了乐观指引,预计收入将增长20%至22%,调整后每股收益增长25%以上,这为投资者注入了强大信心。此外,公司宣布增加股票回购授权,并计划在2026年第一季度动用约3亿美元进行回购。这一资本配置举措彰显了管理层对公司未来现金流和增长前景的信心,旨在优化资本结构并回馈股东,进一步推动了股价的积极表现。","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["PODD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1121674450","title":"银休特公司计划于2026年第一季度斥资约3亿美元进行股票回购","url":"https://stock-news.laohu8.com/highlight/detail?id=1121674450","media":"美股速递","labels":["shareholding","buyback"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1121674450?lang=zh_cn&edition=full","pubTime":"2026-02-18 20:05","pubTimestamp":1771416321,"startTime":"0","endTime":"0","summary":"医疗设备制造商银休特公司近日宣布,将在2026年第一季度启动规模达3亿美元的股票回购计划。这一重大资本配置决策彰显了管理层对公司长期发展前景的坚定信心,同时也反映出企业当前充裕的现金流状况。\n通过回购普通股,公司旨在优化资本结构,提升每股收益水平,从而为股东创造更大价值。该举措预计将有效提振市场信心,进一步巩固银休特在胰岛素输送系统领域的领先地位。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,buyback","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4082","LU2324357040.USD","LU1261432733.SGD","LU2065171402.SGD","LU2065169927.USD","LU2065170008.USD","BK4566","LU1084165304.USD","BK4588","BK4551","PODD","LU1119994496.HKD","LU2065171311.SGD","LU0728928796.USD","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1109269322","title":"银休特宣布Omnipod® 5算法增强通过FDA 510(K)清关,重新定义胰岛素输送并简化Pod体验","url":"https://stock-news.laohu8.com/highlight/detail?id=1109269322","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1109269322?lang=zh_cn&edition=full","pubTime":"2025-12-04 20:01","pubTimestamp":1764849674,"startTime":"0","endTime":"0","summary":"银休特宣布Omnipod® 5算法增强通过FDA 510(K)清关,重新定义胰岛素输送并简化Pod体验","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1261432733.SGD","BK4566","LU2324357040.USD","BK4588","LU0728928796.USD","LU2065171402.SGD","BK4585","LU2065171311.SGD","LU1084165304.USD","BK4551","LU2065170008.USD","LU2065169927.USD","PODD","BK4082","LU1119994496.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2585178074","title":"银休特盘中异动 股价大涨5.02%","url":"https://stock-news.laohu8.com/highlight/detail?id=2585178074","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2585178074?lang=zh_cn&edition=full","pubTime":"2025-11-22 00:52","pubTimestamp":1763743953,"startTime":"0","endTime":"0","summary":"北京时间2025年11月22日00时52分,银休特股票出现波动,股价急速上涨5.02%。银休特股票所在的医疗器械行业中,整体涨幅为2.49%。银休特公司简介:Insulet 成立于2000年,旨在简化糖尿病持续皮下胰岛素输注疗法的使用。其成果是 Omnipod 系统,该系统由一个小型一次性胰岛素输注装置组成,可通过智能手机控制剂量。消息层面,截至00时52分,《瑞士银行上调银休特至买入评级,上调目标价至400美元》资讯为影响银休特的重要信息。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025112200523495130b99&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025112200523495130b99&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU2065171311.SGD","BK4588","LU1119994496.HKD","LU1261432733.SGD","LU0728928796.USD","BK4082","LU1084165304.USD","LU2065169927.USD","BK4585","LU2065170008.USD","LU2324357040.USD","PODD","BK4551","LU2065171402.SGD","BK4566"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1171777838","title":"异动解读 | 银休特季度业绩超预期,股价却盘中大跌5.11%","url":"https://stock-news.laohu8.com/highlight/detail?id=1171777838","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1171777838?lang=zh_cn&edition=full","pubTime":"2025-11-07 00:08","pubTimestamp":1762445314,"startTime":"0","endTime":"0","summary":"医疗设备制造商银休特(Insulet Corp,股票代码:PODD)今日盘中大跌5.11%,引发市场关注。这一跌势与公司刚刚公布的强劲季度业绩形成鲜明对比。\n\n根据公司最新发布的财报,银休特第三季度业绩超出华尔街预期。得益于其可穿戴式胰岛素泵的强劲需求,公司总收入同比大幅增长29.9%,达到7.063亿美元,高于分析师预期的6.7673亿美元。调整后每股收益为1.24美元,同样超过预期的1.14美元。\n\n尽管业绩表现亮眼,银休特股价仍出现大幅下跌。这种反差可能暗示了投资者对公司未来发展的担忧,或者市场存在其他未知因素影响。目前,导致股价下跌的具体原因尚不明确,需要进一步观察市场动向。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["PODD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1172756586","title":"异动解读 | 银休特盘中大涨5.25%,季度业绩超预期且上调全年指引","url":"https://stock-news.laohu8.com/highlight/detail?id=1172756586","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1172756586?lang=zh_cn&edition=full","pubTime":"2025-11-06 22:51","pubTimestamp":1762440686,"startTime":"0","endTime":"0","summary":"医疗设备制造商银休特今日盘中大涨5.25%,股价表现引人注目。该公司最新公布的第三季度财报超出市场预期,同时上调了全年业绩指引,这些积极因素推动了股价的上涨。根据公司财报,银休特第三季度总收入同比增长29.9%,达到7.063亿美元,超过分析师预期的6.7673亿美元。展望未来,银休特上调了2025年全年业绩指引。其中,Omnipod的年收入增长预期被上调至29%至30%。银休特的业绩表现和未来前景反映了医疗设备行业,特别是糖尿病管理领域的持续增长潜力。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["PODD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2518127466","title":"银休特盘中异动 早盘大幅跳水5.00%报239.22美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2518127466","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2518127466?lang=zh_cn&edition=full","pubTime":"2025-03-10 21:46","pubTimestamp":1741614369,"startTime":"0","endTime":"0","summary":"北京时间2025年03月10日21时46分,银休特股票出现异动,股价快速下挫5.00%。截至发稿,该股报239.22美元/股,成交量7.0932万股,换手率0.10%,振幅3.93%。银休特股票所在的医疗器械行业中,整体跌幅为0.88%。银休特公司简介:Insulet成立于2000年,公司的目标是使持续皮下胰岛素输液疗法治疗糖尿病更加容易。自从Omnipod于2005年被美国食品和药物管理局批准以来,全世界大约有425,000名胰岛素依赖型糖尿病患者正在使用Omnipod产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250310214609abf301e2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250310214609abf301e2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU1084165304.USD","PODD","BK4566","BK4551","LU0728928796.USD","LU1119994496.HKD","LU1261432733.SGD","BK4585","BK4588","BK4082","LU2324357040.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2514138160","title":"银休特盘中异动 大幅跳水5.17%报268.83美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514138160","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514138160?lang=zh_cn&edition=full","pubTime":"2025-02-25 23:04","pubTimestamp":1740495874,"startTime":"0","endTime":"0","summary":"北京时间2025年02月25日23时04分,银休特股票出现波动,股价急速跳水5.17%。截至发稿,该股报268.83美元/股,成交量20.2547万股,换手率0.29%,振幅4.83%。最近的财报数据显示,该股实现营业收入20.72亿美元,净利润4.18亿美元,每股收益5.97美元,毛利14.60亿美元,市盈率46.73倍。机构评级方面,在所有24家参与评级的机构中,83%的券商给予买入建议,17%的券商给予持有建议,无券商给予卖出建议。银休特股票所在的医疗器械行业中,整体跌幅为0.27%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250225230435abdc865f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250225230435abdc865f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0728928796.USD","PODD","BK4082","LU1084165304.USD","LU1261432733.SGD","BK4585","BK4588","LU1119994496.HKD","BK4566","BK4551"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2513756172","title":"银休特2024财年实现净利润4.18亿美元,同比增加102.91%","url":"https://stock-news.laohu8.com/highlight/detail?id=2513756172","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2513756172?lang=zh_cn&edition=full","pubTime":"2025-02-24 00:01","pubTimestamp":1740326473,"startTime":"0","endTime":"0","summary":"2月24日,银休特公布财报,公告显示公司2024财年净利润为4.18亿美元,同比增加102.91%;其中营业收入为20.72亿美元,同比增加22.10%,每股基本收益为5.97美元。从资产负债表来看,银休特总负债18.76亿美元,其中短期债务83.80百万美元,资产负债比为1.65,流动比率为3.59。机构评级:截至2025年2月24日,当前有20家机构对银休特目标价做出预测,其中目标均价为319.85美元,其中最低目标价为280.00美元,最高目标价为355.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250224000145a250ce19&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250224000145a250ce19&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["PODD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2513321565","title":"花旗:维持Insulet(PODD.US)评级,由买入调整至买入评级, 目标价由310.00美元调整至355.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2513321565","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2513321565?lang=zh_cn&edition=full","pubTime":"2025-02-22 02:01","pubTimestamp":1740160873,"startTime":"0","endTime":"0","summary":"花旗:维持Insulet(PODD.US)评级,由买入调整至买入评级, 目标价由310.00美元调整至355.00美元。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/02/22020148321154.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["PODD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2513292240","title":"雷蒙德詹姆斯公司:重申Insulet(PODD.US)评级,由优于大市调整至优于大市评级, 目标价由294.00美元调整至328.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2513292240","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2513292240?lang=zh_cn&edition=full","pubTime":"2025-02-22 00:05","pubTimestamp":1740153913,"startTime":"0","endTime":"0","summary":"雷蒙德詹姆斯公司:重申Insulet(PODD.US)评级,由优于大市调整至优于大市评级, 目标价由294.00美元调整至328.00美元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/02/22000548320825.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["PODD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2513299307","title":"Stifel:维持Insulet(PODD.US)评级,由持有调整至持有评级, 目标价由245.00美元调整至293.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2513299307","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2513299307?lang=zh_cn&edition=full","pubTime":"2025-02-21 22:50","pubTimestamp":1740149454,"startTime":"0","endTime":"0","summary":"Stifel:维持Insulet(PODD.US)评级,由持有调整至持有评级, 目标价由245.00美元调整至293.00美元。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/02/21225048320323.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["PODD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2513262260","title":"加拿大投资银行集团:维持Insulet(PODD.US)评级,由买入调整至买入评级, 目标价由304.00美元调整至324.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2513262260","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2513262260?lang=zh_cn&edition=full","pubTime":"2025-02-21 20:40","pubTimestamp":1740141632,"startTime":"0","endTime":"0","summary":"加拿大投资银行集团:维持Insulet(PODD.US)评级,由买入调整至买入评级, 目标价由304.00美元调整至324.00美元。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/02/21204048318759.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["PODD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1116193338","title":"Insulet 2024年第四季度调整后每股收益 $1.15 超预期 $1.02,营收 $597.50M 超预期 $582.81M","url":"https://stock-news.laohu8.com/highlight/detail?id=1116193338","media":"财报速递","labels":["express"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1116193338?lang=zh_cn&edition=full","pubTime":"2025-02-21 05:04","pubTimestamp":1740085466,"startTime":"0","endTime":"0","summary":"Insulet报告季度每股收益为 $1.15,较分析师一致预期的 $1.02 高出 12.75%。与去年同期每股收益 $1.40 相比下降了 17.86%。以上内容来自Benzinga Earnings专栏,原文如下:Insulet reported quarterly earnings of $1.15 per share which beat the analyst consensus estimate of $1.02 by 12.75 percent. This is a 17.86 percent decrease over earnings of $1.40 per share from the same period last year. The company reported quarterly sales of $597.50 million which beat the analyst consensus estimate of $582.81 million by 2.52 percent. This is a 17.20 percent increase","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Insulet 2024年第四季度调整后每股收益 $1.15 超预期 $1.02,营收 $597.50M 超预期 $582.81M","news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PODD"],"isVideo":false,"video":null,"gpt_icon":1}],"profile":{"websiteUrl":"http://www.insulet.com","stockEarnings":[{"period":"1week","weight":-0.0766},{"period":"1month","weight":-0.1546},{"period":"3month","weight":-0.3157},{"period":"6month","weight":-0.4408},{"period":"1year","weight":-0.3005},{"period":"ytd","weight":-0.3842}],"compareEarnings":[{"period":"1week","weight":0.0094},{"period":"1month","weight":0.0998},{"period":"3month","weight":0.0414},{"period":"6month","weight":0.0566},{"period":"1year","weight":0.2904},{"period":"ytd","weight":0.0568}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Insulet Corporation是于2000年成立的一家特拉华州的公司。该公司主要从事开发、制造和销售其专有的胰岛素持续递送系统,用于胰岛素依赖型糖尿病患者。Omnipod平台包括:Omnipod 5自动胰岛素输送系统、Omnipod DASH胰岛素管理系统、Omnipod胰岛素管理系统和最新创新产品Omnipod GOTM,于2023年获得美国食品和药物管理局的许可。该公司还为安进生产Pods,用于Neulasta Onpro试剂盒,这是一种用于安进的Neulasta的递送系统,可帮助降低密集化疗后的感染风险。","yearOnYearQuotes":[{"month":1,"riseRate":0.578947,"avgChangeRate":-0.00575},{"month":2,"riseRate":0.421053,"avgChangeRate":-0.009473},{"month":3,"riseRate":0.631579,"avgChangeRate":0.000145},{"month":4,"riseRate":0.421053,"avgChangeRate":0.008173},{"month":5,"riseRate":0.473684,"avgChangeRate":0.026274},{"month":6,"riseRate":0.789474,"avgChangeRate":0.048531},{"month":7,"riseRate":0.368421,"avgChangeRate":-0.014587},{"month":8,"riseRate":0.789474,"avgChangeRate":0.073949},{"month":9,"riseRate":0.526316,"avgChangeRate":0.010557},{"month":10,"riseRate":0.526316,"avgChangeRate":-0.010123},{"month":11,"riseRate":0.684211,"avgChangeRate":0.083141},{"month":12,"riseRate":0.421053,"avgChangeRate":0.030709}],"exchange":"NASDAQ","name":"银休特","nameEN":"Insulet"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.42.1","shortVersion":"4.42.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"银休特(PODD)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供银休特(PODD)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"银休特,PODD,银休特股票,银休特股票老虎,银休特股票老虎国际,银休特行情,银休特股票行情,银休特股价,银休特股市,银休特股票价格,银休特股票交易,银休特股票购买,银休特股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"银休特(PODD)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供银休特(PODD)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}